Aegerion Pharmaceuticals, Inc. Business Finance Contracts & Agreements
57 Contracts & Agreements
- Assignment Agreements (1 contract)
- Exchange Agreements (2)
- Forbearance Agreements (4)
- Indenture Agreements (2)
- Investor Rights Agreements (2)
- Loan Agreements (12)
- Note Agreements (8)
- Purchase Agreements (1)
- Stock Agreements (18)
- Underwriting Agreements (4)
- Warrant Agreements (3)
- SUPPLEMENTAL INDENTURE (Filed With SEC on November 29, 2016)
- SIXTH AMENDMENT TO FORBEARANCE AGREEMENT (Filed With SEC on November 4, 2016)
- THIRD AMENDMENT TO FORBEARANCE AGREEMENT (Filed With SEC on March 15, 2016)
- SECOND AMENDMENT TO FORBEARANCE AGREEMENT (Filed With SEC on March 15, 2016)
- FIRST AMENDMENT TO FORBEARANCE AGREEMENT (Filed With SEC on March 15, 2016)
- Mark Sumeray Temporary Assignment Plan (Filed With SEC on March 15, 2016)
- AMENDED AND RESTATED INDUCEMENT AWARD STOCK OPTION PLAN SECTION1. GENERAL PURPOSE OF THE PLAN; DEFINITIONS (Filed With SEC on September 23, 2015)
- SIXTH LOAN MODIFICATION AGREEMENT (Filed With SEC on August 17, 2015)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [*] AND HAS BEENFILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on March 2, 2015)
- FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT (Filed With SEC on March 2, 2015)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [*] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on March 2, 2015)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [*] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on March 2, 2015)
- AEGERION PHARMACEUTICALS, INC. 2.00% CONVERTIBLE SENIOR NOTES DUE 2019 INDENTURE DATED AS OF AUGUST 15, 2014 THE BANK OF NEWYORK MELLON TRUST COMPANY, N.A., AS TRUSTEE TABLE OF... (Filed With SEC on August 15, 2014)
- $300,000,000 AegerionPharmaceuticals, Inc. 2.0% Convertible Senior Notes due 2019 PURCHASE AGREEMENT (Filed With SEC on August 12, 2014)
- FOURTH LOAN MODIFICATION AGREEMENT (Filed With SEC on May 9, 2014)
- CONSENT AND THIRD LOAN MODIFICATION AGREEMENT (Filed With SEC on March 3, 2014)
- SECOND LOAN MODIFICATION AGREEMENT (Filed With SEC on March 3, 2014)
- 2,704,739 Shares Aegerion Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 14, 2013)
- FIRST LOAN MODIFICATION AGREEMENT (Filed With SEC on November 9, 2012)
- 3,400,000 Shares Aegerion Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 15, 2012)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on March 29, 2012)
- [ ] Shares Aegerion Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 20, 2011)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on March 4, 2011)
- AEGERION PHARMACEUTICALS, INC. SENIOR SUBORDINATED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 7, 2010)
- AEGERION PHARMACEUTICALS, INC. FOURTH AMENDEDAND RESTATED NOTE PURCHASE AGREEMENT October 1,2010 AEGERION PHARMACEUTICALS, INC. FOURTH AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (Filed With SEC on October 7, 2010)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on October 7, 2010)
- AEGERION PHARMACEUTICALS, INC. 2006 STOCK OPTION AND GRANT PLAN (Filed With SEC on October 7, 2010)
- FULLY PAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $0.001 EACH, OF THE COMMON STOCK OF AEGERION PHARMACEUTICALS, INC. (Filed With SEC on October 7, 2010)
- AEGERION PHARMACEUTICALS, INC. (a Delaware corporation) [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 7, 2010)
- AEGERION PHARMACEUTICALS, INC. SENIOR SUBORDINATED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on August 10, 2010)
- AEGERION PHARMACEUTICALS, INC. THIRD AMENDEDAND RESTATED NOTE PURCHASE AGREEMENT June 14,2010 AEGERION PHARMACEUTICALS, INC. THIRD AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (Filed With SEC on August 10, 2010)
- AMENDED AND RESTATED WARRANT AGREEMENT To Purchase Shares of the Series A Preferred Stock of Aegerion Pharmaceuticals, Inc. Dated as of September 29, 2008 (the Effective Date) (Filed With SEC on August 10, 2010)
- SECURED PROMISSORY NOTE (Filed With SEC on August 10, 2010)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on August 10, 2010)
- AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on August 10, 2010)
- AEGERION PHARMACEUTICALS, INC. 2006 STOCK OPTION AND GRANT PLAN (Filed With SEC on August 10, 2010)
- 2007 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on November 20, 2007)
- WARRANT AGREEMENT To PurchaseShares of the Series A Preferred Stock of Aegerion Pharmaceuticals, Inc. Dated as of March 20, 2007 (the Effective Date) (Filed With SEC on November 20, 2007)
- SECURED PROMISSORY NOTE (Filed With SEC on November 20, 2007)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on November 20, 2007)
